Literature DB >> 8306106

The guinea-pig distal colon--a sensitive preparation for the investigation of 5-HT4 receptor-mediated contractions.

K A Wardle1, G J Sanger.   

Abstract

1. Experiments were designed to characterize pharmacologically the contractile responses to 5-hydroxytryptamine (5-HT) in the guinea-pig isolated distal colon longitudinal muscle-myenteric plexus preparation (LMMP). 2. In the presence of methiothepin (100 nM) and granisetron (1 microM), 5-HT (10 pM-10 nM) produced concentration-dependent contractile responses of the guinea-pig distal colon LMMP, with a pEC50 of 9.2 +/- 0.08. 3. Responses to 5-HT were mimicked by a series of tryptamine analogues, with the following rank order of potency; 5-HT > 5-MeOT >> 5-CT > tryptamine > 2-Me-5-HT. All were found to be full agonists. 4. Responses to 5-HT were also mimicked by a series of substituted benzamide analogues. Their rank order of potency was 5-HT > renzapride > cisapride > (S)-zacopride > (R)-zacopride > metoclopramide. All were full agonists relative to 5-HT. 5. The benzimidazolone derivatives, BIMU 1 and BIMU 8 were approximately equipotent partial agonists (intrinsic activities of 0.8 +/- 0.07 and 0.5 +/- 0.08 respectively) in the guinea-pig distal colon. 6. Tropisetron produced a rightward displacement of the 5-HT concentration-effect curve, yielding an apparent pA2 of 6.4 +/- 0.1. The slope of the Schild plot (1.3 +/- 0.1) was significantly greater than unity. 7. SDZ 205,557 produced a concentration-dependent shift to the right of the 5-HT concentration-response curve, yielding an estimated pA2 of 7.8 +/- 0.1 and a slope which did not significantly deviate from unity. SDZ 205 557 produced similar pKB estimates (7.3-7.9) when tested against 5-MeOT,renzapride and 5-CT, indicating a common site of action.8. The pharmacological profile of the 5-HT-evoked contractions of the guinea-pig distal colon LMMPare consistent with activity at the 5-HT4 receptor. Furthermore, of the models of this receptor described in the literature, the guinea-pig distal colon appears to be the most sensitive model to date, making it a useful tool in the investigation of 5-HT4 receptor-mediated events.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8306106      PMCID: PMC2175885          DOI: 10.1111/j.1476-5381.1993.tb14006.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  SDZ 205-557, a selective antagonist at 5-HT4 receptors in the isolated guinea pig ileum.

Authors:  K H Buchheit; R Gamse; H J Pfannkuche
Journal:  Eur J Pharmacol       Date:  1991-08-06       Impact factor: 4.432

2.  The relationship between the penetration of tryptamine and 5-hydroxytryptamine into smooth muscle and the associated contractions.

Authors:  R E Handschumacher; J R Vane
Journal:  Br J Pharmacol Chemother       Date:  1967-01

3.  A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930.

Authors:  A Dumuis; R Bouhelal; M Sebben; J Bockaert
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

4.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists.

Authors:  R B Parker; D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

5.  Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor.

Authors:  C M Villalón; M O den Boer; J P Heiligers; P R Saxena
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

6.  A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.

Authors:  A Dumuis; R Bouhelal; M Sebben; R Cory; J Bockaert
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

7.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Benzamide derivatives provide evidence for the involvement of a 5-HT4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells.

Authors:  S Idres; C Delarue; H Lefebvre; H Vaudry
Journal:  Brain Res Mol Brain Res       Date:  1991-06

10.  Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain.

Authors:  C J Grossman; G J Kilpatrick; K T Bunce
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

View more
  19 in total

1.  Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.

Authors:  J Mialet; I Berque-Bestel; P Eftekhari; M Gastineau; M Giner; Y Dahmoune; P Donzeau-Gouge; J Hoebeke; M Langlois; S Sicsic; R Fischmeister; F Lezoualc'h
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.

Authors:  J Mialet; I Berque-Bestel; S Sicsic; M Langlois; R Fischmeister; F Lezoualc'h
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

Review 3.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

4.  5-HT4 receptor mediated stimulation of gastric emptying in rats.

Authors:  S S Hegde; A G Wong; M R Perry; P Ku; T M Moy; M Loeb; R M Eglen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-06       Impact factor: 3.000

5.  Selective and functional 5-hydroxytryptamine4 receptor antagonism by SB 207266.

Authors:  K A Wardle; S Bingham; E S Ellis; L M Gaster; B Rushant; M I Smith; G J Sanger
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

6.  The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon.

Authors:  K A Wardle; E S Ellis; G S Baxter; G A Kennett; L M Gaster; G J Sanger
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

Review 7.  Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Authors:  F De Ponti; M Tonini
Journal:  Drugs       Date:  2001       Impact factor: 9.546

8.  Differences in response to 5-HT4 receptor agonists and antagonists of the 5-HT4-like receptor in human colon circular smooth muscle.

Authors:  F S Tam; K Hillier; K T Bunce; C Grossman
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

9.  Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists.

Authors:  E Leung; M T Pulido-Rios; D W Bonhaus; L A Pekins; K D Zeitung; S A Hsu; R D Clark; E H Wong; R M Eglen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

10.  Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.

Authors:  Nicholas L Meyers; Roger I Hickling
Journal:  Drugs R D       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.